Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3054343rdf:typepubmed:Citationlld:pubmed
pubmed-article:3054343lifeskim:mentionsumls-concept:C0030486lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C0030350lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C0817096lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C0205527lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:3054343lifeskim:mentionsumls-concept:C0444467lld:lifeskim
pubmed-article:3054343pubmed:issue5lld:pubmed
pubmed-article:3054343pubmed:dateCreated1988-12-13lld:pubmed
pubmed-article:3054343pubmed:abstractTextEleven patients undergoing operation on the descending or thoracoabdominal aorta were administered papaverine intrathecally in an attempt to protect the spinal cord from ischemic damage. Concurrently, 19 patients, also undergoing operation on the thoracic or thoracoabdominal aorta, were operated on with a variety of conventional techniques, including distal aortic perfusion, but were not given intrathecal papaverine. No signs of early neurologic injury developed in any of the patients in the intrathecal papaverine group, although delayed paraparesis developed in one of the patients (9%; 70% confidence limits = 1% to 28%). On the other hand, eight of 19 patients undergoing operation with conventional techniques had either lower extremity paraparesis or paraplegia postoperatively (42%; 70% confidence limits = 29% to 57%; p = 0.058). Intrathecal papaverine appeared to provide spinal cord protection during thoracic aortic operations, particularly during prolonged periods of aortic cross-clamping. Papaverine was not associated with increased risk and may be superior to other conventionally used modalities. We conclude that continued evaluation of this technique is justified.lld:pubmed
pubmed-article:3054343pubmed:languageenglld:pubmed
pubmed-article:3054343pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3054343pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3054343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3054343pubmed:statusMEDLINElld:pubmed
pubmed-article:3054343pubmed:monthNovlld:pubmed
pubmed-article:3054343pubmed:issn0022-5223lld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:LytleB WBWlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:HinderR ARAlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:GottliebAAlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:FurlanA JAJlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:BevenE GEGlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:StewartR WRWlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:SvenssonL GLGlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:CosgroveD...lld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:GrumD FDFlld:pubmed
pubmed-article:3054343pubmed:authorpubmed-author:AntunesM DMDlld:pubmed
pubmed-article:3054343pubmed:issnTypePrintlld:pubmed
pubmed-article:3054343pubmed:volume96lld:pubmed
pubmed-article:3054343pubmed:ownerNLMlld:pubmed
pubmed-article:3054343pubmed:authorsCompleteNlld:pubmed
pubmed-article:3054343pubmed:pagination823-9lld:pubmed
pubmed-article:3054343pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:meshHeadingpubmed-meshheading:3054343-...lld:pubmed
pubmed-article:3054343pubmed:year1988lld:pubmed
pubmed-article:3054343pubmed:articleTitleIntrathecal papaverine for the prevention of paraplegia after operation on the thoracic or thoracoabdominal aorta.lld:pubmed
pubmed-article:3054343pubmed:affiliationDepartment of Cardiovascular Surgery, Cleveland Clinic Foundation, Ohio.lld:pubmed
pubmed-article:3054343pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3054343pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3054343pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3054343pubmed:publicationTypeControlled Clinical Triallld:pubmed